Objective：To explore the efficacy of the percutaneous vertebroplasty with biopsy forcep for the treatment of Kümmell’s disease. Methods: From May 2015 to March 2018, 32 patients with Kümmell’s disease were treated with percutaneous vertebroplasty with biopsy forcep. There were 8 males and 24 females, with a mean age of 75.4 years. All the patients suffered from low back pain for 4 months to 2 years, which increased with postural changes and released after standing up or bed rest. The anterior vertebral height and Cobb angel were measured on standing lateral radiograph pre- and post-operatively(2 days after operation) and during the final follow-up. Visual analog scale(VAS), Japanese Orthopedic Association(JOA) and Oswestry Index(ODI) were used to evaluate pain and function. Results: There was 1 case with cement leakage, but no neurologic symptom. The anterior vertebral height and Cobb angel of the fractured vertebra recovered respectively from 32.3±8.2）% and （33.5±10.1）° preoperatively to（65.6±3.5）%和（10.3±3.0）° postoperatively. VAS、JOA and ODI improved from 7.8±1.3、13.3±2.1 preoperatively and （82.3±4.5）% to 2.3±1.2、25.3±1.2和（30.3±4.5）% postoperatively. All patients were followed up from 6 to 24 months, with an average of 12.5 months. At the latest follow-up, the anterior vertebral height and Cobb angel of the fractured vertebra were （63.4±4.5）%和（11.3±3.1）°, the VAS, JOA and ODI score were 2.1±2.2、27.3±1.1和（29.3±3.4）% respectively, which had no obvious difference with those of post-operative. Conclusion: Percutaneous vertebroplasty with biopsy forcep for the treatment of Kümmell’s disease is safe and effective.